The Institute for Experiential AI (EAI) is excited to announce the Healthcare Solutions Grant Program, which will allow early stage healthcare companies to leverage the institute’s full slate of offerings to solve their most pressing AI challenges.
The program, which was made possible through funding from the Roux Institute’s Future of Healthcare Founder Residency program, gives healthcare startups a new way to tap into the institute's resources and expertise.
“Access to this caliber of expertise and cutting-edge research stands as a distinctive cornerstone within our residency,” says Elena Brondolo, director of the Future of Healthcare Residency program. “We're firm believers that the key to success for health tech start-ups goes beyond just solid programming. It's about creating an ecosystem where expertise and research are easily accessible. That's really the unique value of having this programming at the Roux."
For the grant program, nine startups currently in the Roux Institute Founder Residency submitted applications describing data science projects to be performed by EAI. A panel of expert researchers in AI and healthcare from the Roux Institute and EAI selected three projects based on factors including the project’s impact, novelty, and potential for education.
The three companies receiving grants are:
Radiolife - Developing a medical device called Cube Scan that can detect the presence of viruses, bacteria and even cancer cells in under 20 seconds without the need for reagents.
PragmaClin - Building a cloud-based patient monitoring and assessment tool to help neurologists assess the progression of Parkinson’s Disease in real time.
Empallo - Developing AI-driven, personalized treatment plans for patients with cardiovascular syndromes and diseases.
“We are thrilled to receive this EAI grant that will be pivotal in advancing our technology," PragmaClin co-founder Bronwyn Bridges says. "It is an honor that the EAI team believes in our mission and is able to help assist us in this opportunity together! Stay tuned as we roll up our sleeves and work diligently to make some big waves alongside this team.”
"The EAI grant is a timely and significant milestone for Radiolife as we strive to revolutionize diagnostics and create a positive impact on people's lives,” Radiolife founder and CEO Sergio Ribeiro says. “This approval marks a pivotal moment in our trajectory, empowering us to harness technology and AI to reshape the future of healthcare. We are deeply grateful for this opportunity and excited to embark on this transformative journey."
The first cohort of the Future of Healthcare Founder Residency at the Roux Institute supports Maine’s growing healthcare technology industry through a partnership with two of Maine’s largest healthcare systems and the Maine Venture Fund.
The grant program represents the latest step in our work helping businesses benefit from the unprecedented potential of AI with human-centric AI solutions. It also exemplifies the integration of Northeastern’s global campus, including the strong ties resulting from co-located EAI and Roux Institute teams.
Finally, the program underscores our commitment to applying AI to real problems by fusing what algorithms do well with what human intelligence does best.